IVIEW Therapeutics, Inc. — Form D/A
IVIEW Therapeutics, Inc. of Cranbury, NJ, a company, filed a Form D amendment with the SEC on 2025-06-10. The offering totals $15.0M, of which $9.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-06-10
- Form: D/A
- Accession: 0001848749-25-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $9.2M
- Remaining: $5.8M
- Investors: 5
- Date of first sale: 2024-05-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-514236
Issuer
- Name: IVIEW Therapeutics, Inc.
- CIK: 0001848749
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5 Cedar Brook Drive, Cranbury, NJ, 08512
- Phone: 6097738580
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Bin He | Director | Cranbury, NJ |
| Houman Hemmati | Director | Beachwood, OH |
| Jingjie Li | Director | Cranbury, NJ |
| Bo Liang | Director | Cranbury, NJ |
| Xiaolu Sun | Director | Cranbury, NJ |
| wei wang | Director | Scarsdale, NY |
| Qi Zhu | Director | Cranbury, NJ |
| Houman Hemmati | Executive Officer | Beachwood, OH |
| Bo Liang | Executive Officer | Cranbury, NJ |
| wei wang | Executive Officer | Scarsdale, NY |
| Qi Zhu | Executive Officer | Cranbury, NJ |
| Tom Tao Du | Director | Cranbury, NJ |
| John J Baldwin | Director | Cranbury, NJ |
| Xiaolu Tao Sun | Director | Cranbury, NJ |
| Bin Tao He | Director | Cranbury, NJ |
| Xiaolu J Sun | Director | Cranbury, NJ |
| Bin J He | Director | Cranbury, NJ |
| Tao J Du | Director | Cranbury, NJ |
| Jun J Du | Director | Doylestown, PA |
Other filings by this issuer (4)
More